CAS: 1005504-62-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
2,4-Quinazolinediamine, 5-[[1-[(2,6-dichlorophenyl)methyl]-4-piperidinyl]methoxy]- REF: AN-AG0002ASCAS: 1005504-62-0 | 98% | 97.00 €~1,421.00 € | Thu 02 May 24 | |
Rg3039 REF: TM-T3336CAS: 1005504-62-0 | 99.58% | 38.00 €~915.00 € | Thu 09 May 24 | |
RG3039 REF: 3D-FQB50462CAS: 1005504-62-0 | Min. 95% | To inquire | Thu 13 Jun 24 |
2,4-Quinazolinediamine, 5-[[1-[(2,6-dichlorophenyl)methyl]-4-piperidinyl]methoxy]-
CAS:1005504-62-0
Formula:
C21H23Cl2N5O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
432.3462
Ref: AN-AG0002AS
2mg | 97.00 € | |
5mg | 135.00 € | |
10mg | 154.00 € | |
25mg | 308.00 € | |
50mg | 626.00 € | |
100mg | 655.00 € | |
500mg | 1,421.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
Rg3039
CAS:1005504-62-0
Rg3039 (PF-06687859) is a potent DcpS inhibitor. DcpS is a therapeutic target for spinal muscular …
Formula:
C21H23Cl2N5O
Purity:
99.58%
Color and Shape:
Solid
Molecular weight:
432.35
Ref: TM-T3336
2mg | 38.00 € | |
5mg | 55.00 € | |
10mg | 91.00 € | |
25mg | 159.00 € | |
50mg | 253.00 € | |
100mg | 407.00 € | |
500mg | 915.00 € | |
1ml*10 (DMSO) | 62.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
RG3039
CAS:1005504-62-0
RG3039 is a novel small molecule that has been shown to have anti-leukemic activity in …
Formula:
C21H23Cl2N5O
Purity:
Min. 95%
Molecular weight:
432.35 g/mol
Ref: 3D-FQB50462
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024